Analytical Method Development That Survives Validation and Transfer
Robust, reproducible, ICH-aligned methods for HPLC, UHPLC, LC-MS/MS, and GC-MS. We develop stability-indicating, impurity, and assay methods built to pass validation the first time — and transfer cleanly to your site or CRO.
Why Method Development Projects Fail
Most analytical delays don't come from testing — they come from methods that were never robust enough to begin with. These are the failure points HIPSOUL is built to eliminate.
Methods That Collapse at Validation
A method that works once on one instrument is not a validated method. Poor robustness, undefined system suitability, and untested ruggedness lead to failed validation runs, wasted batches, and slipped submission dates.
Methods That Won't Transfer
Methods developed without transfer in mind break the moment they reach a different lab, analyst, or instrument — forcing costly re-development at your manufacturing site or CRO.
Methods That Miss Degradation Products
Without forced degradation and proper peak purity assessment, a method cannot prove it separates the API from its degradants — a guaranteed regulatory deficiency in stability programmes.
Impurities That Co-Elute
Methods that fail to resolve closely-related substances, isomers, or genotoxic impurities at reporting thresholds produce data that cannot support an ICH-compliant impurity profile.
No Existing Method for Your Molecule
Novel APIs, complex biological matrices, and difficult analytes often have no pharmacopoeial method — and many testing-only labs lack the development capability to create one from scratch.
Legacy Methods Draining Throughput
Long run times, high solvent consumption, and poor reproducibility in older HPLC methods inflate cost-per-sample and bottleneck your QC and release testing.
Method Development Across Every Technique
From a single robust HPLC assay to a multi-analyte LC-MS/MS impurity method, HIPSOUL develops, optimises, and prepares methods for validation and transfer — all under one quality system, using FABI-driven scientific design.
HPLC Method Development
Reversed-phase, normal-phase, and ion-exchange method design with systematic column, mobile phase, gradient, and detection optimisation for assay, purity, and related substances.
UHPLC Method Development
Sub-2-micron method design and HPLC-to-UHPLC conversion that cuts run time and solvent cost while raising resolution — without sacrificing robustness or transferability.
LC-MS/MS Method Development
MRM transition development, source optimisation, and matrix-effect mitigation for trace quantification, genotoxic impurities, and structure confirmation at ppm/ppb levels.
GC-MS Method Development
Method design for residual solvents (ICH Q3C), volatile impurities, and extractables/leachables — including headspace and derivatisation optimisation.
Impurity Method Development
Stability-indicating impurity methods with forced degradation, peak purity, and mass balance — resolving related substances and genotoxic impurities per ICH Q3A/B/D.
Stability-Indicating Methods
Methods proven to separate the active from all degradation products through structured stress studies — the foundation of any defensible ICH Q1A stability programme.
Sample Preparation Optimisation
Extraction, clean-up, and SPE optimisation that improves recovery, removes matrix interference, and makes methods rugged across analysts and sample lots.
Method Transfer & Troubleshooting
Transfer protocols, comparative validation support, and root-cause diagnosis to rescue failing legacy methods or move methods cleanly between sites and CROs.
A Structured Path from Molecule to Validated Method
Method development is not trial-and-error at HIPSOUL. A defined, scientific workflow gives you predictable timelines, full visibility, and a method package built for validation from day one.
Requirement & Scope Definition
We capture your analyte, matrix, regulatory context, target performance, and end-use (QC, release, stability, or submission). NDA signed before any technical disclosure.
Method Scouting & Screening
Systematic screening of columns, mobile phases, pH, and detection conditions to identify the most selective, robust starting point — not the first one that works.
Optimisation & Robustness Design
Gradient, resolution, sensitivity, and run-time optimisation with deliberate robustness testing, so the method holds up under real-world variation.
Forced Degradation & Verification
For stability-indicating and impurity methods, structured stress studies confirm specificity, peak purity, and mass balance against all degradants.
Pre-Validation & Transfer Package
System suitability criteria, method parameters, and complete documentation prepared for seamless validation and transfer to your site or CRO.
Instruments Built for Development-Grade Work
Method development demands instrument flexibility, not just routine throughput. Our laboratory runs a modern, fully qualified fleet that lets us scout conditions across techniques and detectors, then lock in the most robust configuration — all under IQ/OQ/PQ qualification and 21 CFR Part 11-compliant data management.
- Waters ACQUITY UPLC & Agilent 1260/1290 Systems with Quaternary Solvent Management for Scouting
- Triple Quadrupole LC-MS/MS (ESI/APCI) for MRM Development & Matrix-Effect Studies
- GC-MS/FID with Headspace for Residual Solvent & Volatile Method Design
- PDA / DAD Detectors for Peak Purity & Spectral Confirmation
- Column Library Spanning C18, C8, Phenyl, HILIC, Chiral & Ion-Exchange Chemistries
- Validated Stability Chambers (ICH Zones I–IV) for Forced Degradation Studies
- 21 CFR Part 11-Compliant Chromatography Data Systems (Empower / OpenLAB)
Method Development for Your Industry
Every sector brings its own matrices, regulations, and analytes. Our development approach is tailored to the requirements that matter to you.
Method Development in Action
Real development projects, measurable outcomes — methods that passed validation and transferred without re-work.
Pharmaceutical
Stability-Indicating Method for a Novel API
A pharmaceutical client needed a stability-indicating HPLC method for a new API with three known degradants. HIPSOUL completed scouting, forced degradation, and method finalisation with full peak-purity confirmation, ready for validation.
Food & Beverage
HPLC-to-UHPLC Conversion for High-Throughput QC
A food manufacturer's legacy HPLC additive method ran 35 minutes per sample. HIPSOUL redeveloped it on UHPLC, preserving resolution while cutting run time and solvent use dramatically — multiplying daily QC throughput.
Biotechnology
LC-MS/MS Method Transfer to Client CRO
A biotech firm needed a peptide-impurity LC-MS/MS method moved to its contract lab. HIPSOUL produced a full transfer protocol and co-validation support, achieving a first-pass transfer with no re-development required.
Frequently Asked Questions
Answers to the questions technical buyers ask most before starting a HIPSOUL method development project.
What does your method development service include?
Full development from requirement definition through scouting, optimisation, robustness testing, forced degradation (where applicable), and a pre-validation and transfer documentation package. We can continue into full method validation as a single-source engagement.
Do you develop methods aligned with ICH guidelines?
Yes. Our development follows ICH Q2 and Q14 principles for analytical procedure development and validation, with stability-indicating work designed around ICH Q1A and impurity methods around ICH Q3A/B/D. Documentation is structured for regulatory submission.
Can you make an existing method stability-indicating?
Yes. We perform structured forced degradation studies, assess peak purity and mass balance, and refine the method until it demonstrably separates the active from all degradation products — converting a basic assay into a defensible stability-indicating method.
Will the method transfer to our site or CRO?
Transferability is designed in from the start. We build robustness into every method and provide a complete transfer package with system suitability criteria, plus co-validation support, so methods move between labs and instruments without re-development.
How long does method development take?
A typical single-analyte method takes 2–4 weeks; complex multi-analyte impurity or LC-MS/MS methods take longer. Stability-indicating methods include forced degradation time. Exact timelines are confirmed in your project quotation.
Do you sign NDAs and protect novel compounds?
Yes. We sign mutual NDAs before any technical discussion. Novel APIs, proprietary formulations, and unpublished structures are held in strict confidence and never disclosed to third parties.
Can you develop a method for a compound with no existing pharmacopoeial method?
Yes — that is a core strength. We routinely develop methods from first principles for novel molecules, difficult analytes, and complex matrices where no compendial method exists.
Do you accept international projects and samples?
Yes. We work with clients across the USA, Europe, India, Australia, and the Middle East, and advise on import/export documentation for APIs and regulated materials.
Still have questions about your specific method?
Talk to an ExpertRequest a Quote for Your Method Development Project
No-obligation quote within 24–48 hours. NDA signed before any technical discussion. Trusted by pharmaceutical, biotech, food, cosmetic, and research clients across the USA, Europe, India, Australia, and the Middle East.
Strict confidentiality & NDA on all projects · ICH-aligned documentation · Quote within 24–48 hours
